Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_23101 | 397 | 8.28 | Mlig455_048080 | Neo: - Age: - Region-enriched R2: 3.122/0.00807 |
Mlig455_048080 {REF} {Length: 721} {TRANSSPLICED} {RNA1509_16955} {RNA1310_49452, RNA1509_16955} {RNA1509_16955, RNA815_4585} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 0.636 | 3.47 | 0.71116 | 1.00000 | |
RegionR2 | 3.122 | 3.47 | 0.00026 | 0.00807 | |
RegionR3 | 0.154 | 3.47 | 0.82785 | 1.00000 | |
RegionR4 | -0.574 | 3.47 | 0.57153 | 0.88952 | |
RegionR5 | -1.378 | 3.47 | 0.13566 | 0.37689 | |
RegionR6 | 0.459 | 3.47 | 0.56784 | 1.00000 | |
RegionR7 | 0.172 | 3.47 | 0.84562 | 1.00000 | |
RegionR8 | -2.591 | 3.47 | 0.17072 | 0.74547 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -7.38 | 3.47 | 0.12007 | 0.84997 | |
RegenerationR2 | -2.338 | 3.47 | 0.00527 | 0.11462 | |
RegenerationR3 | -1.971 | 3.47 | 0.02754 | 0.29834 | |
RegenerationR4 | -2.04 | 3.47 | 0.03513 | 0.30240 | |
RegenerationR5 | -1.361 | 3.47 | 0.17413 | 0.60343 | |
RegenerationR6 | -2.686 | 3.47 | 0.00967 | 0.12088 | |
RegenerationBL | -0.662 | 3.47 | 0.62496 | 0.96742 | |
RegenerationTP | 0.858 | 3.47 | 0.52463 | 0.91666 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_23101 | 397 | 8.28 | Mlig455_048080 | Neo: - Age: - Region-enriched R2: 3.122/0.00807 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_048080 {REF} {Length: 721} {TRANSSPLICED} {RNA1509_16955} {RNA1310_49452, RNA1509_16955} {RNA1509_16955, RNA815_4585} | |
2. | MligTC455_48720 | 1367 | 28.48 | Mlig455_017034 | Neo: - Age: - Region-specific R2: 4.593 Region-enriched R2: 3.164/0.00157 |
4.536 | 0.785 | 0.983 | 0.829 | 0.994 | 0.945 | - | Mlig455_017034 {REF} {Length: 866} {RNA1509_17554, RNA1509_28146} {RNA1310_40772, RNA1509_28146} {RNA1509_28146, RNA815_29897} | |
3. | MligTC455_46009 | 5464 | 113.82 | Mlig455_061251, Mlig455_062639 | Neo: - Age: logFC(26M/2M)=-0.276 Region-specific R2: 2.871 Region-enriched R2: 2.103/0.00001 |
4.513 | 0.750 | 0.969 | 0.913 | 0.928 | 0.953 | - | Mlig455_061251 {REF} {Length: 1343} {Smed: dd_Smed_v6_1520_0_1, dd_Smed_v6_1520_0_1, [Score=54.7, Expect=6e-10]} {RNA1509_3086} {RNA1310_72677.2} {RNA815_25863} Mlig455_062639 {REF} {Length: 1176} {Smed: dd_Smed_v6_1520_0_1, dd_Smed_v6_1520_0_1, [Score=54.7, Expect=6e-10]} {RNA1509_3086} {RNA1310_72677.2} {RNA815_25863} |
|
4. | MligTC455_45622 | 647 | 13.48 | Mlig455_069391 | Neo: - Age: - Region-specific R2: 5.132 Region-enriched R2: 3.915/0.00000 Regeneration-downregulated R2: -2.412 Regeneration-depleted R2: -2.412 |
4.496 | 0.875 | 0.771 | 0.934 | 0.987 | 0.929 | - | Mlig455_069391 {REF} {Length: 971} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=45.1, Expect=4e-07]} {RNA1509_31982} {RNA1310_46295} {RNA815_23543} | |
5. | MligTC455_15726 | 270 | 5.63 | Mlig455_031204 | Neo: - Age: - Region-enriched R2: 6.820/0.00015 |
ADAMTS18 | 4.445 | 0.984 | 0.874 | 0.755 | 0.986 | 0.846 | - | Mlig455_031204 {REF} {Length: 2405} {Pfam: Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=77.6]; Metallo-peptidase family M12 [PF13688.8, score=52.5]; Metallo-peptidase family M12B Reprolysin-like [PF13583.8, score=45.6]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=41.4]; ADAM cysteine-rich domain [PF17771.3, score=40.0]; Metallo-peptidase family M12B Reprolysin-like [PF13574.8, score=30.9]; Astacin (Peptidase family M12A) [PF01400.26, score=19.3]} {Human: ENSG00000140873, ADAMTS18, ADAM metallopeptidase with thrombospondin type 1 motif 18, [Score=90.9, Expect=1e-18]} {Mouse: ENSMUSG00000049538, Adamts16, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 16, [Score=90.1, Expect=1e-18]; ENSMUSG00000053399, Adamts18, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 18, [Score=89.7, Expect=2e-18]} {Dmel: FBgn0034903, sona, sol narae, [RH, Score=114, Expect=7e-27]} {Celegans: WBGene00003248, mig-17, ADAM family mig-17, [RH, Score=100, Expect=2e-22]} {RNA1509_42775} {RNA1310_19585.1, RNA1509_42775} {RNA1509_42775, RNA815_17997} |
6. | MligTC455_23100 | 527 | 10.99 | Mlig455_019660 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.306 Region-enriched R2: 3.360/0.00019 |
4.417 | 0.803 | 0.975 | 0.716 | 0.991 | 0.932 | - | Mlig455_019660 {REF} {Length: 2113} {RNA1509_29678} {RNA1310_49452, RNA1509_29678} {RNA1509_29678, RNA815_4585} | |
7. | MligTC455_43557 | 362 | 7.55 | Mlig455_059172, Mlig455_065527 | Neo: - Age: Down-Down-Up Region-specific R2: 6.284 Region-enriched R2: 5.832/0.00001 |
ANKRD63 | 4.367 | 0.975 | 0.786 | 0.767 | 0.937 | 0.902 | - | Mlig455_059172 {REF} {Length: 1739} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=53.2]; Ankyrin repeats (many copies) [PF13637.8, score=42.6]; Ankyrin repeat [PF13606.8, score=27.6]; Ankyrin repeats (many copies) [PF13857.8, score=27.1]; Ankyrin repeat [PF00023.32, score=25.9]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [Score=68.2, Expect=7e-12]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [Score=67.4, Expect=7e-12]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=49.3, Expect=7e-06]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=49.3, Expect=4e-06]} {Smed: dd_Smed_v6_10280_0_1, dd_Smed_v6_10280_0_1, [Score=81.3, Expect=1e-16]} {RNA1310_44826} {RNA815_62096} Mlig455_065527 {REF} {Length: 2998} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=52.3]; Ankyrin repeats (many copies) [PF13637.8, score=42.0]; Ankyrin repeats (many copies) [PF13857.8, score=26.7]; Ankyrin repeat [PF00023.32, score=26.0]; Ankyrin repeat [PF13606.8, score=22.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [Score=68.2, Expect=7e-12]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [Score=68.2, Expect=6e-12]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=50.1, Expect=5e-06]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=50.4, Expect=2e-06]} {Smed: dd_Smed_v6_10280_0_1, dd_Smed_v6_10280_0_1, [Score=80.9, Expect=2e-16]} {RNA1509_30872} {RNA1310_44826} {RNA815_62096} |
8. | MligTC455_41448 | 192 | 4.01 | Mlig455_066626 | Neo: - Age: - Region-specific R2: 6.449 Region-enriched R2: 4.988/0.02499 |
4.328 | 0.894 | 0.726 | 0.809 | 0.982 | 0.917 | - | Mlig455_066626 {REF} {Length: 987} {Pfam: F5/8 type C domain [PF00754.27, score=25.0]} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=52.4, Expect=8e-09]} {RNA1509_36923} {RNA1310_37535} {RNA815_20943} | |
9. | MligTC455_45620 | 1952 | 40.67 | Mlig455_002357 | Neo: - Age: Down-Up-Up Region-enriched R2: 2.487/0.00094 Regeneration-depleted BL: -3.636 |
4.27 | 0.773 | 0.748 | 0.859 | 0.956 | 0.934 | - | Mlig455_002357 {REF} {Length: 933} {RNA1509_8166} {RNA1310_46295} {RNA815_23543} | |
10. | MligTC455_15546 | 141 | 2.93 | Mlig455_021744 | Neo: - Age: - |
4.263 | 0.985 | 0.817 | 0.767 | 0.948 | 0.746 | - | Mlig455_021744 {REF} {Length: 1839} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=60.5]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=26.5]} {Mouse: ENSMUSG00000039079, Trhr2, thyrotropin releasing hormone receptor 2, [Score=51.2, Expect=1e-06]} {Dmel: FBgn0053696, CNMaR, CNMamide Receptor, [Score=72.0, Expect=3e-13]} {Celegans: WBGene00020586, frpr-18, FLP-2 receptor; FMRFamide Peptide Receptor family, [Score=69.3, Expect=2e-12]} {Smed: dd_Smed_v6_25364_0_1, dd_Smed_v6_25364_0_1, [RH, Score=197, Expect=7e-59]} {RNA1310_26850} {RNA815_17444} | |
11. | MligTC455_19758 | 53 | 1.1 | Mlig455_002464 | Neo: - Age: - Region-enriched R2: 6.578/0.02863 |
4.22 | 0.984 | 0.762 | 0.790 | 0.967 | 0.717 | - | Mlig455_002464 {REF} {Length: 2549} {RNA1310_38437} {RNA815_40458} | |
12. | MligTC455_21665 | 1283 | 26.74 | Mlig455_000443, Mlig455_000504 | Neo: - Age: logFC(26M/2M)=-0.231 Region-specific R2: 3.326 Region-enriched R2: 2.174/0.00141 |
PPP3R1 | 4.198 | 0.742 | 0.835 | 0.710 | 0.948 | 0.963 | - | Mlig455_000443 {REF} {Length: 1489} {Pfam: EF hand [PF00036.34, score=92.6]; EF-hand domain pair [PF13499.8, score=86.6]; EF-hand domain [PF13405.8, score=74.3]; EF hand [PF13202.8, score=72.6]; EF-hand domain pair [PF13833.8, score=65.7]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=30.2]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=27.0]; EF-hand domain [PF14658.8, score=21.7]} {Human: ENSG00000221823, PPP3R1, protein phosphatase 3 regulatory subunit B, alpha, [RH, Score=289, Expect=5e-101]} {Mouse: ENSMUSG00000033953, Ppp3r1, protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I), [RH, Score=289, Expect=3e-101]} {Dmel: FBgn0010014, CanB, Calcineurin B, [RH, Score=282, Expect=1e-98]} {Celegans: WBGene00000554, cnb-1, Protein phosphatase 2B regulatory subunit cnb-1, [RH, Score=272, Expect=7e-95]} {Smed: dd_Smed_v6_5589_0_1, dd_Smed_v6_5589_0_1, [RH, Score=281, Expect=1e-98]} {RNA1509_14613, RNA1509_39549} {RNA1310_16848.2, RNA1509_14613, RNA1509_39549} {RNA1509_14613, RNA1509_39549, RNA815_6272} Mlig455_000504 {REF} {Length: 1689} {Pfam: EF hand [PF00036.34, score=90.0]; EF-hand domain pair [PF13499.8, score=84.5]; EF-hand domain [PF13405.8, score=71.9]; EF hand [PF13202.8, score=69.8]; EF-hand domain pair [PF13833.8, score=63.4]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=28.7]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=25.4]; EF-hand domain [PF14658.8, score=19.6]} {Human: ENSG00000221823, PPP3R1, protein phosphatase 3 regulatory subunit B, alpha, [RH, Score=290, Expect=2e-100]} {Mouse: ENSMUSG00000033953, Ppp3r1, protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I), [RH, Score=290, Expect=1e-100]} {Dmel: FBgn0010014, CanB, Calcineurin B, [RH, Score=283, Expect=4e-98]} {Celegans: WBGene00000554, cnb-1, Protein phosphatase 2B regulatory subunit cnb-1, [RH, Score=274, Expect=3e-94]} {Smed: dd_Smed_v6_5589_0_1, dd_Smed_v6_5589_0_1, [RH, Score=283, Expect=3e-98]} {RNA1509_39549} {RNA1310_16848.2} {RNA815_6272} |
13. | MligTC455_26004 | 161 | 3.34 | Mlig455_005523, Mlig455_036228 | Neo: - Age: logFC(26M/2M)=0.483 Region-enriched R2: 3.880/0.02863 |
4.187 | 0.905 | 0.717 | 0.709 | 0.954 | 0.902 | - | Mlig455_005523 {REF} {Length: 3106} {RNA1509_54312} {RNA1310_125315} {RNA815_31978} Mlig455_036228 {REF} {Length: 3817} {RNA1509_54312} {RNA1310_75243} {RNA815_31978} |
|
14. | MligTC455_47537 | 1546 | 32.22 | Mlig455_025825, Mlig455_067628 | Neo: - Age: - Region-enriched R2: 2.005/0.00057 |
CALM2 | 4.006 | - | 0.957 | 0.740 | 0.727 | 0.802 | 0.780 | Mlig455_025825 {REF} {Length: 1517} {Pfam: EF-hand domain pair [PF13499.8, score=110.1]; EF hand [PF00036.34, score=108.5]; EF-hand domain pair [PF13833.8, score=85.9]; EF hand [PF13202.8, score=77.9]; EF-hand domain [PF13405.8, score=74.6]; EF-hand domain [PF14658.8, score=42.9]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=28.9]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=28.2]; EF hand [PF14788.8, score=19.6]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=97.8, Expect=1e-25]; ENSG00000198668, CALM1, calmodulin 1, [Score=96.7, Expect=9e-26]; ENSG00000160014, CALM3, calmodulin 3, [Score=96.7, Expect=9e-26]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=97.8, Expect=2e-26]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=96.7, Expect=6e-26]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=96.7, Expect=6e-26]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=96.7, Expect=6e-26]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=96.7, Expect=5e-26]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=96.7, Expect=4e-26]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=96.7, Expect=3e-26]} {RNA1509_17413, RNA1509_39138} {RNA1310_29051, RNA1509_17413, RNA1509_39138} {RNA1509_17413, RNA1509_39138, RNA815_15566.1} Mlig455_067628 {REF} {Length: 858} {TRANSSPLICED} {Pfam: EF-hand domain pair [PF13499.8, score=109.8]; EF hand [PF00036.34, score=108.3]; EF-hand domain pair [PF13833.8, score=85.1]; EF hand [PF13202.8, score=77.7]; EF-hand domain [PF13405.8, score=74.4]; EF-hand domain [PF14658.8, score=41.4]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=29.1]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=28.4]; EF hand [PF14788.8, score=19.7]; Dockerin type I domain [PF00404.20, score=19.2]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=98.2, Expect=1e-25]; ENSG00000160014, CALM3, calmodulin 3, [Score=97.1, Expect=8e-26]; ENSG00000198668, CALM1, calmodulin 1, [Score=97.1, Expect=8e-26]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=98.2, Expect=2e-26]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=97.1, Expect=5e-26]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=97.1, Expect=5e-26]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=97.1, Expect=5e-26]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=97.4, Expect=3e-26]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=97.1, Expect=2e-26]} {Smed: dd_Smed_v6_414_0_1, dd_Smed_v6_414_0_1, [Score=97.1, Expect=2e-26]} {RNA1509_33581, RNA1509_39138, RNA1509_52504} {RNA1310_29051, RNA1509_33581, RNA1509_52504} {RNA1509_33581, RNA1509_52504, RNA815_15566.1} |
15. | MligTC455_15332 | 44 | 0.93 | Mlig455_062622, Mlig455_067527 | Neo: - Age: - Region-enriched R2: 7.516/0.00418 |
ASIC4 | 3.731 | 0.985 | - | 0.813 | 0.974 | 0.959 | - | Mlig455_062622 {REF} {Length: 2228} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=73.0]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=47.4, Expect=7e-06]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=51.6, Expect=2e-07]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=55.8, Expect=3e-09]} {Smed: dd_Smed_v6_19727_0_1, dd_Smed_v6_19727_0_1, [Score=53.1, Expect=2e-08]} {RNA1310_17847} {RNA815_27317} Mlig455_067527 {REF} {Length: 1916} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=147.3]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=50.1, Expect=1e-05]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=50.8, Expect=3e-06]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_19727_0_1, dd_Smed_v6_19727_0_1, [Score=53.5, Expect=2e-07]} {RNA1310_17847} {RNA815_27317} |
16. | MligTC455_48127 | 47 | 0.97 | Mlig455_037173 | Neo: - Age: - |
3.708 | 0.962 | - | 0.831 | 0.992 | 0.923 | - | Mlig455_037173 {REF} {Length: 1938} {RNA1310_42908} {RNA815_22744} | |
17. | MligTC455_03731 | 113 | 2.35 | Mlig455_066791 | Neo: - Age: - |
3.687 | 0.981 | - | 0.839 | 0.921 | 0.946 | - | Mlig455_066791 {REF} {Length: 1679} {Smed: dd_Smed_v6_13648_0_1, dd_Smed_v6_13648_0_1, [RH, Score=79.7, Expect=2e-16]} {RNA1509_58026} {RNA1310_23180, RNA1509_58026} {RNA1509_58026, RNA815_34008} | |
18. | MligTC455_32554 | 51 | 1.07 | Mlig455_024179 | Neo: - Age: - |
3.685 | 0.965 | - | 0.819 | 0.964 | 0.937 | - | Mlig455_024179 {REF} {Length: 926} {RNA1509_24504} {RNA1310_3168} {RNA815_18309} | |
19. | MligTC455_53233 | 1483 | 30.9 | Mlig455_037746, Mlig455_069921 | Neo: - Age: - Region-specific R2: 7.323 Region-enriched R2: 7.524/0.00000 Regeneration-downregulated R2: -3.635 Regeneration-depleted R2: -3.635 |
PKD2 | 3.647 | 0.860 | - | 0.883 | 0.954 | 0.950 | - | Mlig455_037746 {REF} {Length: 3024} {Pfam: Polycystin cation channel [PF08016.14, score=468.5]; Ion transport protein [PF00520.33, score=85.9]; EF-hand domain pair [PF13499.8, score=21.3]; EF hand [PF00036.34, score=21.2]; EF-hand domain [PF13405.8, score=18.2]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=708, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=306, Expect=2e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=379, Expect=1e-119]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=719, Expect=0.0]} {RNA1509_30624, RNA1509_6992} {RNA1310_6033, RNA1509_30624} {RNA1509_30624, RNA815_1577.1} Mlig455_069921 {REF} {Length: 3030} {Pfam: Polycystin cation channel [PF08016.14, score=467.0]; Ion transport protein [PF00520.33, score=85.5]; EF hand [PF00036.34, score=21.3]; EF-hand domain pair [PF13499.8, score=21.3]; EF-hand domain [PF13405.8, score=18.3]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=707, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=304, Expect=8e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=377, Expect=3e-119]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=716, Expect=0.0]} {RNA1509_6992} {RNA1310_6033, RNA1509_6992} {RNA1509_6992, RNA815_1577.1} |
20. | MligTC455_32575 | 62 | 1.29 | Mlig455_024198 | Neo: - Age: logFC(26M/2M)=-0.353 |
FAT4 | 3.646 | 0.925 | - | 0.829 | 0.958 | 0.934 | - | Mlig455_024198 {REF} {Length: 7971} {Pfam: Cadherin domain [PF00028.19, score=704.5]; Cadherin-like [PF16184.7, score=77.6]; Cadherin-like [PF08266.14, score=39.5]} {Human: ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=501, Expect=3e-142]; ENSG00000107736, CDH23, cadherin related 23, [Score=498, Expect=1e-141]} {Mouse: ENSMUSG00000046743, Fat4, FAT atypical cadherin 4, [Score=514, Expect=1e-146]; ENSMUSG00000012819, Cdh23, cadherin 23 (otocadherin), [Score=504, Expect=1e-143]} {Dmel: FBgn0284247, ds, dachsous, [Score=457, Expect=3e-129]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=277, Expect=2e-74]} {Smed: dd_Smed_v6_7638_0_1, dd_Smed_v6_7638_0_1, [Score=276, Expect=8e-74]} {RNA1509_24504} {RNA1310_3168, RNA1509_24504} {RNA1509_24504, RNA815_13217} |
21. | MligTC455_27785 | 115 | 2.39 | Mlig455_001141 | Neo: - |
HMCN2 | 3.64 | 0.972 | - | 0.830 | 0.904 | 0.934 | - | Mlig455_001141 {REF} {Length: 2156} {Pfam: von Willebrand factor type A domain [PF13519.8, score=54.7]; von Willebrand factor type A domain [PF13768.8, score=30.6]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=81.3, Expect=2e-15]} {Mouse: ENSMUSG00000007030, Vwa7, von Willebrand factor A domain containing 7, [Score=79.0, Expect=6e-15]; ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=77.8, Expect=2e-14]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=96.3, Expect=1e-20]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=79.7, Expect=2e-15]} {RNA1509_38050} {RNA1310_19586} {RNA815_17693} |
22. | MligTC455_45730 | 87 | 1.81 | Mlig455_020296 | Neo: - Age: Down-Up-Up Region-enriched R2: 8.589/0.00002 |
SSUH2 | 3.633 | 0.985 | 0.879 | - | 0.946 | 0.823 | - | Mlig455_020296 {REF} {Length: 1680} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=197, Expect=3e-59]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=155, Expect=9e-44]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=127, Expect=5e-33]} {RNA1310_19609.2} {RNA815_22113.1} |
23. | MligTC455_25412 | 199 | 4.15 | Mlig455_008720, Mlig455_063581 | Neo: - Age: - Region-enriched R2: 7.484/0.00035 |
CNBD2 | 3.625 | 0.982 | - | 0.817 | 0.876 | 0.950 | - | Mlig455_008720 {REF} {Length: 2602} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=82.1]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=52.4, Expect=3e-06]} {Smed: dd_Smed_v6_13623_0_1, dd_Smed_v6_13623_0_1, [Score=241, Expect=1e-69]} {RNA1509_50931} {RNA1310_3304} {RNA815_12767} Mlig455_063581 {REF} {Length: 2668} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=82.3]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=52.4, Expect=3e-06]} {Smed: dd_Smed_v6_13623_0_1, dd_Smed_v6_13623_0_1, [Score=241, Expect=7e-70]} {RNA1509_50931} {RNA1310_3304} {RNA815_12767} |
24. | MligTC455_21801 | 58 | 1.22 | Mlig455_015442, Mlig455_032138 | Neo: - Age: - |
NPY1R | 3.619 | 0.720 | 0.971 | - | 0.993 | 0.935 | - | Mlig455_015442 {REF} {Length: 2461} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=130.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=26.2]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=18.9]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=128, Expect=5e-32]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=122, Expect=2e-30]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=140, Expect=4e-36]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=120, Expect=1e-29]} {Smed: dd_Smed_v6_25204_0_1, dd_Smed_v6_25204_0_1, [Score=208, Expect=2e-61]} {RNA1310_49156} {RNA815_43783} Mlig455_032138 {REF} {Length: 2633} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=129.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.9]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=18.6]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=126, Expect=2e-31]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=122, Expect=4e-30]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=136, Expect=1e-34]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_25934_0_1, dd_Smed_v6_25934_0_1, [Score=207, Expect=5e-61]} {RNA1310_49156} {RNA815_43783} |
25. | MligTC455_24951 | 220 | 4.58 | Mlig455_052169 | Neo: - Age: - Region-specific R2: 4.554 Region-enriched R2: 4.264/0.00008 Regeneration-downregulated R2: -1.743 Regeneration-depleted R2: -1.743 |
CCDC169 | 3.606 | 0.965 | - | 0.783 | 0.966 | 0.892 | - | Mlig455_052169 {REF} {Length: 1369} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545} |
26. | MligTC455_48128 | 18 | 0.37 | Mlig455_052326 | Neo: - Age: - |
3.6 | 0.978 | - | 0.779 | 0.910 | 0.933 | - | Mlig455_052326 {REF} {Length: 3582} {RNA1310_42908} {RNA815_22744} | |
27. | MligTC455_33814 | 559 | 11.65 | Mlig455_061944 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.446/0.00053 |
MOXD1 | 3.583 | 0.839 | - | 0.906 | 0.881 | 0.957 | - | Mlig455_061944 {REF} {Length: 2816} {Pfam: Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=105.5]; Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=67.8]} {Human: ENSG00000079931, MOXD1, monooxygenase DBH like 1, [Score=129, Expect=2e-31]} {Mouse: ENSMUSG00000020000, Moxd1, monooxygenase, DBH-like 1, [Score=141, Expect=1e-35]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=116, Expect=3e-27]} {Celegans: WBGene00006541, tbh-1, Tyramine beta-hydroxylase, [Score=129, Expect=9e-32]} {Smed: dd_Smed_v6_42610_0_1, dd_Smed_v6_42610_0_1, [Score=120, Expect=7e-30]} {RNA1509_41983} {RNA1310_8990, RNA1509_41983} {RNA1509_41983, RNA815_3230} |
28. | MligTC455_42841 | 550 | 11.45 | Mlig455_019999 | Neo: - Age: logFC(26M/2M)=-0.374 Region-specific R2: 6.903 Region-enriched R2: 6.896/0.00000 |
DDC | 3.564 | 0.845 | - | 0.810 | 0.991 | 0.918 | - | Mlig455_019999 {REF} {Length: 3000} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=395.1]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [Score=444, Expect=3e-151]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [Score=436, Expect=5e-148]} {Dmel: FBgn0050446, Tdc2, Tyrosine decarboxylase 2, [Score=457, Expect=2e-154]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [Score=445, Expect=1e-149]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [Score=449, Expect=3e-153]} {RNA1509_57403} {RNA1310_9852} {RNA815_3388.1} |
29. | MligTC455_46502 | 168 | 3.5 | Mlig455_010557 | Neo: - Age: - |
3.562 | 0.960 | - | 0.813 | 0.949 | 0.840 | - | Mlig455_010557 {REF} {Length: 557} {Pfam: HalX domain [PF08663.12, score=24.3]} {RNA1509_57107} {RNA1310_80026, RNA1509_57107} {RNA1509_57107, RNA815_41799} | |
30. | MligTC455_13165 | 181 | 3.77 | Mlig455_018648 | Neo: - Age: - Region-specific R2: 6.131 Region-enriched R2: 4.463/0.01828 Regeneration-downregulated R2: -3.253 Regeneration-depleted R2: -3.253 |
3.556 | 0.958 | - | 0.745 | 0.945 | 0.908 | - | Mlig455_018648 {REF} {Length: 1920} {TRANSSPLICED} {Pfam: FAD dependent oxidoreductase [PF01266.26, score=209.8]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=21.6]; FAD binding domain [PF01494.21, score=20.4]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=19.9]; FAD binding domain [PF00890.26, score=18.9]} {Mouse: ENSMUSG00000033624, Pdpr, pyruvate dehydrogenase phosphatase regulatory subunit, [Score=51.6, Expect=2e-06]} {Smed: dd_Smed_v6_5776_0_1, dd_Smed_v6_5776_0_1, [RH, Score=246, Expect=2e-77]} {RNA1509_25789} {RNA1310_15994} {RNA815_21830} | |
31. | MligTC455_24953 | 749 | 15.61 | Mlig455_060716 | Neo: - Age: - Region-specific R2: 5.313 Region-enriched R2: 5.509/0.00000 |
CCDC169 | 3.54 | 0.950 | - | 0.787 | 0.887 | 0.916 | - | Mlig455_060716 {REF} {Length: 1302} {TRANSSPLICED} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545} |
32. | MligTC455_21668 | 84 | 1.74 | Mlig455_024837 | Neo: - |
PPP3R1 | 3.533 | 0.958 | - | 0.773 | 0.953 | 0.849 | - | Mlig455_024837 {REF} {Length: 1650} {Pfam: EF hand [PF00036.34, score=92.6]; EF-hand domain pair [PF13499.8, score=86.6]; EF-hand domain [PF13405.8, score=74.3]; EF hand [PF13202.8, score=72.6]; EF-hand domain pair [PF13833.8, score=65.7]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=30.2]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=27.0]; EF-hand domain [PF14658.8, score=21.7]} {Human: ENSG00000221823, PPP3R1, protein phosphatase 3 regulatory subunit B, alpha, [RH, Score=289, Expect=5e-101]} {Mouse: ENSMUSG00000033953, Ppp3r1, protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I), [RH, Score=289, Expect=3e-101]} {Dmel: FBgn0010014, CanB, Calcineurin B, [RH, Score=282, Expect=1e-98]} {Celegans: WBGene00000554, cnb-1, Protein phosphatase 2B regulatory subunit cnb-1, [RH, Score=272, Expect=7e-95]} {Smed: dd_Smed_v6_5589_0_1, dd_Smed_v6_5589_0_1, [RH, Score=281, Expect=1e-98]} {RNA1509_14613} {RNA1310_16848.1} {RNA815_6272} |
33. | MligTC455_24952 | 637 | 13.28 | Mlig455_054178, Mlig455_060727 | Neo: - Age: Down-Up-Down Region-specific R2: 4.165 Region-enriched R2: 3.160/0.00003 Regeneration-downregulated BL: -4.774 Regeneration-depleted BL: -4.774 |
CCDC169 | 3.532 | 0.959 | - | 0.740 | 0.927 | 0.906 | - | Mlig455_054178 {REF} {Length: 1390} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545} Mlig455_060727 {REF} {Length: 1391} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029, RNA1509_8270} {RNA1509_8270, RNA815_11545} |
34. | MligTC455_45621 | 610 | 12.72 | Mlig455_041531 | Neo: - Age: - Region-specific R2: 5.645 Region-enriched R2: 4.169/0.00001 |
3.51 | - | 0.803 | 0.786 | 0.988 | 0.933 | - | Mlig455_041531 {REF} {Length: 1004} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=45.1, Expect=4e-07]} {RNA1509_31982, RNA1509_8166} {RNA1310_46295, RNA1509_31982, RNA1509_8166} {RNA1509_31982, RNA1509_8166, RNA815_23543} | |
35. | MligTC455_45414 | 4030 | 83.95 | Mlig455_045096 | Neo: - Age: Down-Down-Up Region-specific R2: 2.245 Region-enriched R2: 1.386/0.00025 Regeneration-depleted TP: -1.938 |
3.506 | - | 0.988 | 0.749 | 0.850 | 0.919 | - | Mlig455_045096 {REF} {Length: 1427} {RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192} {RNA1310_24092, RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192} {RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192, RNA815_369.1} | |
36. | MligTC455_24244 | 290 | 6.04 | Mlig455_062623, Mlig455_067528, Mlig455_070336 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.603/0.00020 |
3.479 | 0.708 | - | 0.836 | 0.989 | 0.946 | - | Mlig455_062623 {REF} {Length: 1154} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=68.1]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=71.6, Expect=3e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_067528 {REF} {Length: 1190} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.0]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=72.4, Expect=1e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_070336 {REF} {Length: 859} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.7]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [Score=57.4, Expect=1e-10]} {RNA1310_40891} {RNA815_16565} |
|
37. | MligTC455_16199 | 114 | 2.37 | Mlig455_041013, Mlig455_041178 | Neo: Irradiation Age: - Region-enriched R2: 9.007/0.00037 |
3.443 | 0.975 | - | 0.836 | 0.929 | 0.703 | - | Mlig455_041013 {REF} {Length: 3381} {RNA1509_42904} {RNA1310_20434} {RNA815_22064} Mlig455_041178 {REF} {Length: 2722} {RNA1509_42904} {RNA1310_20004} {RNA815_22064} |
|
38. | MligTC455_44712 | 665 | 13.86 | Mlig455_017186 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.471 Region-specific R2: 4.141 Region-enriched R2: 3.536/0.00000 |
3.423 | - | 0.950 | 0.763 | 0.826 | 0.884 | - | Mlig455_017186 {REF} {Length: 1018} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
39. | MligTC455_40867 | 6445 | 134.27 | Mlig455_005155, Mlig455_021617 | Neo: - Age: Down-Up-Up Region-specific R2: 3.705 Region-enriched R2: 2.406/0.00000 Regeneration-depleted BL: -3.516 |
3.409 | - | 0.950 | 0.911 | 0.707 | 0.841 | - | Mlig455_005155 {REF} {Length: 850} {RNA1509_3536} {RNA1310_30272} {RNA815_20224} Mlig455_021617 {REF} {Length: 851} {RNA1509_3536} {RNA1310_30272} {RNA815_20224} |
|
40. | MligTC455_50410 | 31 | 0.64 | Mlig455_020239 | Neo: - Age: - |
GRIA2 | 3.407 | - | 0.814 | 0.701 | 0.968 | 0.924 | - | Mlig455_020239 {REF} {Length: 2096} {Pfam: Ligand-gated ion channel [PF00060.28, score=192.2]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=127.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=91.1]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=513, Expect=7e-173]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=496, Expect=3e-166]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=494, Expect=8e-167]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=491, Expect=1e-164]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=507, Expect=4e-171]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=497, Expect=4e-167]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=494, Expect=1e-165]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=491, Expect=1e-164]} {Dmel: FBgn0038837, CG3822, [Score=432, Expect=1e-142]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [Score=459, Expect=5e-152]} {Smed: dd_Smed_v6_7562_0_1, dd_Smed_v6_7562_0_1, [Score=528, Expect=2e-179]} {RNA1509_56139} {RNA1310_38868} {RNA815_32684} |
41. | MligTC455_49557 | 280 | 5.82 | Mlig455_017273 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.728 Region-specific R2: 3.642 Region-enriched R2: 3.187/0.00196 |
3.404 | - | 0.762 | 0.740 | 0.967 | 0.935 | - | Mlig455_017273 {REF} {Length: 1333} {RNA1509_52848} {RNA1310_64923, RNA1509_52848} {RNA1509_52848, RNA815_51063} | |
42. | MligTC455_18599 | 119 | 2.47 | Mlig455_031197 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.553/0.00808 |
3.396 | 0.975 | 0.788 | - | 0.744 | 0.889 | - | Mlig455_031197 {REF} {Length: 1284} {RNA1310_35452} | |
43. | MligTC455_38775 | 266 | 5.54 | Mlig455_066758, Mlig455_069705 | Neo: - Age: - Region-specific R2: 6.147 Region-enriched R2: 5.505/0.02411 |
WNT6 | 3.372 | - | 0.776 | 0.777 | 0.988 | 0.831 | - | Mlig455_066758 {REF} {Length: 2739} {Pfam: wnt family [PF00110.21, score=158.2]} {Human: ENSG00000115596, WNT6, Wnt family member 6, [Score=77.4, Expect=9e-15]; ENSG00000134245, WNT2B, Wnt family member 2B, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [Score=74.3, Expect=6e-14]; ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [Score=74.3, Expect=9e-14]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=70.9, Expect=9e-13]} {Celegans: WBGene00000857, cwn-1, [Score=73.9, Expect=4e-14]} {Smed: dd_Smed_v6_13487_0_1, dd_Smed_v6_13487_0_1, [Score=71.2, Expect=3e-13]} {RNA1509_23528} {RNA1310_12823.2} {RNA815_8552} Mlig455_069705 {REF} {Length: 2713} {Pfam: wnt family [PF00110.21, score=158.2]} {Human: ENSG00000115596, WNT6, Wnt family member 6, [Score=77.4, Expect=1e-14]; ENSG00000134245, WNT2B, Wnt family member 2B, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [Score=74.3, Expect=7e-14]; ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [Score=73.9, Expect=1e-13]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=70.9, Expect=9e-13]} {Celegans: WBGene00000857, cwn-1, [Score=73.6, Expect=6e-14]} {Smed: dd_Smed_v6_13487_0_1, dd_Smed_v6_13487_0_1, [Score=70.9, Expect=3e-13]} {RNA1509_23528} {RNA1310_12823.1, RNA1509_23528} {RNA1509_23528, RNA815_8552} |
44. | MligTC455_14683 | 2425 | 50.53 | Mlig455_039611 | Neo: - Age: Down-Up-Up |
PAM | 3.359 | - | 0.958 | 0.774 | 0.734 | 0.893 | - | Mlig455_039611 {REF} {Length: 1708} {Pfam: NHL repeat [PF01436.23, score=88.3]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [RH, Score=191, Expect=5e-54]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=198, Expect=4e-56]} {Dmel: FBgn0262728, Pal2, Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase 2, [RH, Score=206, Expect=2e-62]} {Celegans: WBGene00017671, pgal-1, Probable peptidyl-alpha-hydroxyglycine alpha-amidating lyase pgal-1, [RH, Score=204, Expect=2e-62]} {Smed: dd_Smed_v6_3093_0_1, dd_Smed_v6_3093_0_1, [RH, Score=251, Expect=4e-80]} {RNA1509_910, RNA1509_9422} {RNA1310_18216.1, RNA1509_9422} {RNA1509_9422, RNA815_736.1} |
45. | MligTC455_48757 | 61 | 1.28 | Mlig455_008828, Mlig455_008932 | Neo: - Age: Up-Down-Up |
DDC | 3.359 | 0.970 | 0.786 | 0.738 | 0.865 | - | - | Mlig455_008828 {REF} {Length: 2057} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=471.9]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [RH, Score=572, Expect=0.0]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [RH, Score=558, Expect=0.0]} {Dmel: FBgn0000422, Ddc, Dopa decarboxylase, [RH, Score=553, Expect=0.0]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [RH, Score=545, Expect=0.0]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [RH, Score=563, Expect=0.0]} {RNA1310_37174} {RNA815_42090} Mlig455_008932 {REF} {Length: 2145} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=470.1]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [RH, Score=574, Expect=0.0]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [RH, Score=559, Expect=0.0]} {Dmel: FBgn0000422, Ddc, Dopa decarboxylase, [RH, Score=554, Expect=0.0]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [RH, Score=545, Expect=0.0]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [RH, Score=564, Expect=0.0]} {RNA1310_37174} {RNA815_42090} |
46. | MligTC455_41968 | 247 | 5.15 | Mlig455_048152 | Neo: - Age: - Region-specific R2: 5.996 Region-enriched R2: 5.206/0.00199 |
3.351 | - | 0.972 | 0.722 | 0.839 | 0.818 | - | Mlig455_048152 {REF} {Length: 932} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=22.6]} {RNA1509_40628} {RNA1310_50753} {RNA815_21607} | |
47. | MligTC455_46903 | 255 | 5.3 | Mlig455_040553 | Neo: - Age: - Region-enriched R2: 9.597/0.00026 |
3.348 | 0.701 | - | 0.825 | 0.950 | 0.872 | - | Mlig455_040553 {REF} {Length: 562} {RNA1509_45949} {RNA1310_70304, RNA1509_45949} {RNA1509_45949, RNA815_37653} | |
48. | MligTC455_22125 | 178 | 3.71 | Mlig455_028579, Mlig455_028597 | Neo: - Age: - Region-enriched R2: 5.949/0.00261 |
3.345 | 0.755 | - | 0.712 | 0.968 | 0.910 | - | Mlig455_028579 {REF} {Length: 993} {RNA1509_54214} {RNA1310_51652} {RNA815_36975} Mlig455_028597 {REF} {Length: 962} {RNA1509_54214} {RNA1310_51652} {RNA815_36975} |
|
49. | MligTC455_50861 | 422 | 8.78 | Mlig455_050457 | Neo: - Age: Down-Up-Down Region-enriched R2: 2.760/0.00000 |
CPLX2 | 3.339 | - | 0.874 | 0.706 | 0.808 | 0.951 | - | Mlig455_050457 {REF} {Length: 2902} {Pfam: Synaphin protein [PF05835.14, score=85.3]} {Human: ENSG00000145920, CPLX2, complexin 2, [RH, Score=55.1, Expect=1e-10]} {Mouse: ENSMUSG00000025867, Cplx2, complexin 2, [RH, Score=50.8, Expect=1e-08]} {Dmel: FBgn0041605, cpx, complexin, [Score=64.3, Expect=7e-14]} {Celegans: WBGene00022271, cpx-1, Putative complexin-1, [Score=71.2, Expect=1e-16]} {Smed: dd_Smed_v6_9918_0_1, dd_Smed_v6_9918_0_1, [Score=78.6, Expect=1e-19]} {RNA1509_56433} {RNA1310_16525, RNA1509_56433} {RNA1509_56433, RNA815_8066.1} |
50. | MligTC455_14684 | 7049 | 146.85 | Mlig455_051414 | Neo: - Age: - Region-specific R2: 2.287 Region-enriched R2: 1.764/0.00001 Regeneration-depleted BL: -2.197 |
PAM | 3.338 | - | 0.982 | 0.702 | 0.769 | 0.885 | - | Mlig455_051414 {REF} {Length: 1674} {TRANSSPLICED} {Pfam: NHL repeat [PF01436.23, score=89.1]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [RH, Score=194, Expect=4e-55]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=201, Expect=4e-57]} {Dmel: FBgn0262728, Pal2, Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase 2, [RH, Score=206, Expect=4e-62]} {Celegans: WBGene00017671, pgal-1, Probable peptidyl-alpha-hydroxyglycine alpha-amidating lyase pgal-1, [RH, Score=206, Expect=3e-63]} {Smed: dd_Smed_v6_3093_0_1, dd_Smed_v6_3093_0_1, [RH, Score=249, Expect=2e-79]} {RNA1509_910} {RNA1310_18216.1, RNA1509_910} {RNA1509_910, RNA815_736.1} |
51. | MligTC455_33861 | 424 | 8.83 | Mlig455_015736, Mlig455_049442 | Neo: - Age: Up-Down-Up Region-specific R2: 4.103 Region-enriched R2: 3.209/0.00115 |
EML1 | 3.309 | - | 0.707 | 0.794 | 0.983 | 0.825 | - | Mlig455_015736 {REF} {Length: 5118} {Pfam: Doublecortin [PF03607.19, score=58.2]; HELP motif [PF03451.16, score=47.1]; WD domain, G-beta repeat [PF00400.34, score=41.2]; Anaphase-promoting complex subunit 4 WD40 domain [PF12894.9, score=26.5]} {Human: ENSG00000066629, EML1, echinoderm microtubule associated protein like 1, [Score=317, Expect=3e-91]; ENSG00000143924, EML4, echinoderm microtubule associated protein like 4, [Score=313, Expect=7e-89]; ENSG00000125746, EML2, echinoderm microtubule associated protein like 2, [Score=307, Expect=2e-88]} {Mouse: ENSMUSG00000058070, Eml1, echinoderm microtubule associated protein like 1, [Score=324, Expect=3e-94]; ENSMUSG00000032624, Eml4, echinoderm microtubule associated protein like 4, [Score=321, Expect=1e-91]} {Dmel: FBgn0259099, DCX-EMAP, Doublecortin-domain-containing echinoderm-microtubule-associated protein, [Score=330, Expect=3e-96]} {Celegans: WBGene00001248, elp-1, Echinoderm microtubule-associated protein-like elp-1, [Score=129, Expect=6e-30]} {Smed: dd_Smed_v6_2493_0_1, dd_Smed_v6_2493_0_1, [Score=298, Expect=1e-83]} {RNA1509_31406} {RNA1310_20171} {RNA815_13503} Mlig455_049442 {REF} {Length: 4806} {Pfam: Doublecortin [PF03607.19, score=58.7]; HELP motif [PF03451.16, score=47.6]; WD domain, G-beta repeat [PF00400.34, score=32.6]; Anaphase-promoting complex subunit 4 WD40 domain [PF12894.9, score=27.5]} {Human: ENSG00000066629, EML1, echinoderm microtubule associated protein like 1, [Score=317, Expect=4e-92]; ENSG00000143924, EML4, echinoderm microtubule associated protein like 4, [Score=311, Expect=7e-89]; ENSG00000125746, EML2, echinoderm microtubule associated protein like 2, [Score=308, Expect=5e-89]} {Mouse: ENSMUSG00000058070, Eml1, echinoderm microtubule associated protein like 1, [Score=324, Expect=3e-95]; ENSMUSG00000032624, Eml4, echinoderm microtubule associated protein like 4, [Score=319, Expect=1e-91]} {Dmel: FBgn0259099, DCX-EMAP, Doublecortin-domain-containing echinoderm-microtubule-associated protein, [Score=331, Expect=3e-97]} {Celegans: WBGene00001248, elp-1, Echinoderm microtubule-associated protein-like elp-1, [Score=133, Expect=2e-31]} {Smed: dd_Smed_v6_2493_0_1, dd_Smed_v6_2493_0_1, [Score=296, Expect=2e-83]} {RNA1509_31406} {RNA1310_20171} {RNA815_13503} |
52. | MligTC455_40051 | 36 | 0.76 | Mlig455_025990 | Neo: - Age: logFC(26M/2M)=-0.633 |
PRKCE | 3.305 | 0.982 | - | 0.715 | 0.740 | 0.868 | - | Mlig455_025990 {REF} {Length: 2622} {Pfam: Protein kinase domain [PF00069.27, score=102.7]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=69.5]; Kinase-like [PF14531.8, score=19.5]} {Human: ENSG00000171132, PRKCE, protein kinase C epsilon, [Score=84.3, Expect=1e-16]} {Mouse: ENSMUSG00000045038, Prkce, protein kinase C, epsilon, [Score=82.0, Expect=5e-16]} {Dmel: FBgn0283472, S6k, Ribosomal protein S6 kinase, [Score=79.0, Expect=2e-15]} {Celegans: WBGene00009793, pkn-1, Protein Kinase N (PKN) homolog, [Score=73.2, Expect=2e-13]} {Smed: dd_Smed_v6_8010_0_1, dd_Smed_v6_8010_0_1, [Score=77.8, Expect=4e-15]} {RNA1509_36146} {RNA1310_24732} {RNA815_64704} |
53. | MligTC455_31463 | 20 | 0.42 | Mlig455_057169 | Neo: - Age: - |
3.3 | 0.972 | - | 0.837 | 0.723 | 0.768 | - | Mlig455_057169 {REF} {Length: 1647} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=39.0]} {Smed: dd_Smed_v6_12148_0_2, dd_Smed_v6_12148_0_2, [Score=82.4, Expect=3e-18]} {RNA1509_6604} {RNA1310_43619} {RNA815_6128.2} | |
54. | MligTC455_31462 | 23 | 0.48 | Mlig455_000844 | Neo: - Age: - |
3.299 | 0.962 | - | 0.837 | 0.730 | 0.770 | - | Mlig455_000844 {REF} {Length: 2564} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=39.1]} {Smed: dd_Smed_v6_12148_0_2, dd_Smed_v6_12148_0_2, [Score=81.6, Expect=5e-18]} {RNA1509_6604} {RNA1310_43619} {RNA815_6128.2} | |
55. | MligTC455_53240 | 1601 | 33.35 | Mlig455_025555 | Neo: - Age: - Region-specific R2: 4.178 Region-enriched R2: 2.883/0.00000 |
3.277 | - | 0.983 | 0.757 | 0.755 | 0.782 | - | Mlig455_025555 {REF} {Length: 2163} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=28.0]} {Dmel: FBgn0051221, CG31221, [RH, Score=69.7, Expect=2e-14]} {Celegans: WBGene00010290, F58H1.7, [Score=64.7, Expect=4e-13]} {Smed: dd_Smed_v6_2598_0_1, dd_Smed_v6_2598_0_1, [RH, Score=168, Expect=3e-53]} {RNA1509_58542} {RNA1310_40950, RNA1509_58542} {RNA1509_58542, RNA815_19778.1} | |
56. | MligTC455_20574 | 3347 | 69.74 | Mlig455_021418 | Neo: - Age: - |
PCSK2 | 3.274 | - | 0.963 | 0.713 | 0.807 | 0.791 | - | Mlig455_021418 {REF} {Length: 1212} {Pfam: Peptidase S8 pro-domain [PF16470.7, score=47.7]} {Human: ENSG00000125851, PCSK2, proprotein convertase subtilisin/kexin type 2, [Score=53.9, Expect=2e-08]} {Mouse: ENSMUSG00000027419, Pcsk2, proprotein convertase subtilisin/kexin type 2, [Score=52.8, Expect=4e-08]} {Dmel: FBgn0023179, amon, amontillado, [Score=55.8, Expect=2e-09]} {Celegans: WBGene00001172, egl-3, Neuroendocrine convertase 2, [Score=61.2, Expect=3e-11]} {Smed: dd_Smed_v6_1566_0_1, dd_Smed_v6_1566_0_1, [Score=65.1, Expect=1e-12]} {RNA1509_15978} {RNA1310_7333.1} {RNA815_2403.2} |
57. | MligTC455_45597 | 116 | 2.41 | Mlig455_049417 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.185/0.02405 |
3.268 | 0.983 | 0.774 | 0.729 | 0.782 | - | - | Mlig455_049417 {REF} {Length: 1106} {RNA1310_45744} {RNA815_56662} | |
58. | MligTC455_41628 | 140 | 2.91 | Mlig455_015910 | Neo: - Age: - |
RYK | 3.25 | 0.841 | - | 0.707 | 0.964 | 0.738 | - | Mlig455_015910 {REF} {Length: 2784} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=111.2]; WIF domain [PF02019.20, score=98.1]; Protein kinase domain [PF00069.27, score=37.2]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.3]} {Human: ENSG00000163785, RYK, receptor-like tyrosine kinase, [Score=135, Expect=3e-33]} {Mouse: ENSMUSG00000032547, Ryk, receptor-like tyrosine kinase, [Score=136, Expect=2e-33]} {Dmel: FBgn0033791, Drl-2, Derailed 2, [Score=195, Expect=2e-53]} {Celegans: WBGene00003007, lin-18, Inactive tyrosine-protein kinase RYK, [Score=116, Expect=4e-27]} {Smed: dd_Smed_v6_12594_0_2, dd_Smed_v6_12594_0_2, [Score=135, Expect=3e-33]} {RNA1310_8002.1} {RNA815_18265} |
59. | MligTC455_33442 | 39 | 0.81 | Mlig455_039767 | Neo: - Age: - |
2.822 | 0.954 | - | - | 0.943 | 0.925 | - | Mlig455_039767 {REF} {Length: 1975} {RNA1310_42391} | |
60. | MligTC455_44120 | 125 | 2.61 | Mlig455_041513 | Neo: - Age: Up-Down-Down Region-enriched R2: 7.169/0.00020 |
2.807 | - | 0.938 | - | 0.960 | 0.909 | - | Mlig455_041513 {REF} {Length: 644} {NoTransDecoderORF} {RNA1310_39164} {RNA815_4344} | |
61. | MligTC455_25382 | 4668 | 97.26 | Mlig455_000103, Mlig455_063773 | Neo: - Age: - Region-specific R2: 3.508 Region-enriched R2: 3.123/0.00000 |
2.794 | - | 0.970 | - | 0.994 | 0.830 | - | Mlig455_000103 {REF} {Length: 990} {RNA1509_36813} {RNA1310_39295, RNA1509_36813} {RNA1509_36813, RNA815_13177} Mlig455_063773 {REF} {Length: 890} {RNA1509_6028} {RNA1310_39295} {RNA815_13177} |
|
62. | MligTC455_47704 | 106 | 2.21 | Mlig455_032247 | Neo: - |
WSCD2 | 2.786 | 0.942 | - | - | 0.984 | 0.860 | - | Mlig455_032247 {REF} {Length: 2305} {Pfam: WSC domain [PF01822.21, score=58.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=54.7, Expect=1e-07]; ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.8, Expect=5e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.6, Expect=3e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.9, Expect=1e-10]} {RNA1509_59284} {RNA1310_13567} {RNA815_27780} |
63. | MligTC455_27332 | 6690 | 139.38 | Mlig455_034839, Mlig455_034841, Mlig455_034842 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=0.609 Region-specific R2: 8.988 Region-enriched R2: 9.169/0.00000 Regeneration-depleted R2: -8.701 |
2.762 | - | - | 0.842 | 0.984 | 0.936 | - | Mlig455_034839 {REF} {Length: 551} {RNA1509_2874} {RNA1310_102625.1} {RNA815_20834} Mlig455_034841 {REF} {Length: 529} {RNA1509_2874} {RNA1310_102625.1, RNA1509_2874} {RNA1509_2874, RNA815_20834} Mlig455_034842 {REF} {Length: 557} {RNA1509_2874} {RNA1310_102625.1} {RNA815_20834} |
|
64. | MligTC455_35000 | 20 | 0.42 | Mlig455_050562 | Neo: - Age: - |
KCNC1 | 2.751 | 0.977 | - | 0.837 | - | 0.937 | - | Mlig455_050562 {REF} {Length: 3042} {Pfam: Ion transport protein [PF00520.33, score=116.8]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=42.0]} {Human: ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=211, Expect=2e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=209, Expect=1e-58]; ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=206, Expect=3e-56]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=204, Expect=3e-57]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=204, Expect=1e-55]; ENSG00000131398, KCNC3, potassium voltage-gated channel subfamily C member 3, [Score=203, Expect=7e-56]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=212, Expect=3e-60]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=209, Expect=2e-57]; ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=206, Expect=2e-56]; ENSMUSG00000027895, Kcnc4, potassium voltage gated channel, Shaw-related subfamily, member 4, [Score=204, Expect=4e-57]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=203, Expect=1e-56]; ENSMUSG00000062785, Kcnc3, potassium voltage gated channel, Shaw-related subfamily, member 3, [Score=203, Expect=4e-56]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=223, Expect=2e-65]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=224, Expect=8e-65]} {Smed: dd_Smed_v6_20858_0_1, dd_Smed_v6_20858_0_1, [RH, Score=567, Expect=0.0]} {RNA1509_22940} {RNA1310_28483} {RNA815_31040} |
65. | MligTC455_09595 | 48 | 1.01 | Mlig455_030009 | Neo: - Age: - |
OPRM1 | 2.75 | 0.962 | - | - | 0.968 | 0.820 | - | Mlig455_030009 {REF} {Length: 1508} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=44.4]; Serpentine type 7TM GPCR chemoreceptor Sra [PF02117.18, score=19.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=19.6]} {Human: ENSG00000112038, OPRM1, opioid receptor mu 1, [Score=56.2, Expect=5e-08]} {Mouse: ENSMUSG00000000766, Oprm1, opioid receptor, mu 1, [Score=54.7, Expect=9e-08]} {Celegans: WBGene00021510, frpr-19, FMRFamide Peptide Receptor family, [Score=47.8, Expect=7e-06]} {RNA1310_43388} {RNA815_47203} |
66. | MligTC455_17644 | 182 | 3.8 | Mlig455_007930, Mlig455_008033 | Neo: - Age: - |
2.747 | 0.928 | - | - | 0.956 | 0.863 | - | Mlig455_007930 {REF} {Length: 2086} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=20.9]} {Smed: dd_Smed_v6_25359_0_1, dd_Smed_v6_25359_0_1, [Score=66.2, Expect=3e-12]} {RNA1509_7841} {RNA1310_25567} {RNA815_6213} Mlig455_008033 {REF} {Length: 1974} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=20.6]} {Smed: dd_Smed_v6_25359_0_1, dd_Smed_v6_25359_0_1, [Score=66.2, Expect=4e-12]} {RNA1509_7841} {RNA1310_25567} {RNA815_6213} |
|
67. | MligTC455_20016 | 607 | 12.65 | Mlig455_041914 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.404 Region-enriched R2: 5.008/0.00002 |
2.743 | - | - | 0.972 | 0.866 | 0.905 | - | Mlig455_041914 {REF} {Length: 745} {Pfam: EF-hand domain [PF13405.8, score=60.3]; EF hand [PF00036.34, score=52.6]; EF-hand domain pair [PF13499.8, score=49.5]; EF hand [PF13202.8, score=40.2]; EF-hand domain [PF14658.8, score=30.6]; EF-hand domain pair [PF13833.8, score=30.2]} {Dmel: FBgn0052103, CG32103, [Score=43.5, Expect=1e-05]} {Smed: dd_Smed_v6_16347_0_2, dd_Smed_v6_16347_0_2, [Score=67.8, Expect=1e-15]} {RNA1509_17125, RNA1509_40839} {RNA1310_56976, RNA1509_40839} {RNA1509_40839, RNA815_29327} | |
68. | MligTC455_18161 | 771 | 16.05 | Mlig455_031626, Mlig455_048205 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.318/0.00160 |
2.741 | 0.988 | - | - | 0.942 | 0.811 | - | Mlig455_031626 {REF} {Length: 835} {TRANSSPLICED} {RNA1509_48514} {RNA1310_56583, RNA1509_48514} {RNA1509_48514, RNA815_34758} Mlig455_048205 {REF} {Length: 651} {RNA1509_48514} {RNA1310_56583} {RNA815_34758} |
|
69. | MligTC455_46775 | 3655 | 76.14 | Mlig455_034423 | Neo: - Age: - Region-enriched R2: 6.976/0.00000 |
CAV1 | 2.74 | - | - | 0.909 | 0.962 | 0.869 | - | Mlig455_034423 {REF} {Length: 1041} {Pfam: Caveolin [PF01146.19, score=114.3]} {Human: ENSG00000105974, CAV1, caveolin 1, [Score=94.7, Expect=4e-25]; ENSG00000182533, CAV3, caveolin 3, [Score=92.4, Expect=3e-24]} {Mouse: ENSMUSG00000007655, Cav1, caveolin 1, caveolae protein, [Score=92.4, Expect=2e-24]; ENSMUSG00000062694, Cav3, caveolin 3, [Score=91.3, Expect=6e-24]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=70.9, Expect=1e-15]} {Smed: dd_Smed_v6_8555_0_1, dd_Smed_v6_8555_0_1, [Score=130, Expect=1e-39]} {RNA1509_5585, RNA1509_8418} {RNA1310_21291.2, RNA1509_5585, RNA1509_8418} {RNA1509_5585, RNA1509_8418, RNA815_11992} |
70. | MligTC455_40791 | 75 | 1.56 | Mlig455_013501 | Neo: - Age: - Region-enriched R2: 7.804/0.01222 |
2.72 | - | - | 0.815 | 0.979 | 0.926 | - | Mlig455_013501 {REF} {Length: 2310} {Pfam: WSC domain [PF01822.21, score=57.5]; F5/8 type C domain [PF00754.27, score=52.4]; Clip-domain serine protease homolog Scarface [PF18399.3, score=20.3]} {Smed: dd_Smed_v6_52492_0_1, dd_Smed_v6_52492_0_1, [Score=58.5, Expect=2e-10]} {RNA1509_16751} {RNA1310_14302.1} {RNA815_6113.1} | |
71. | MligTC455_33636 | 175 | 3.64 | Mlig455_027209, Mlig455_050659 | Neo: - Age: logFC(26M/2M)=-0.416 Region-enriched R2: 3.904/0.00709 |
CHRNA10 | 2.703 | 0.871 | - | - | 0.992 | 0.840 | - | Mlig455_027209 {REF} {Length: 1614} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=99.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=74.0]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=152, Expect=1e-40]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=150, Expect=8e-40]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=148, Expect=6e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=150, Expect=3e-40]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=150, Expect=5e-40]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=144, Expect=5e-38]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=133, Expect=1e-33]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=142, Expect=3e-37]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=142, Expect=3e-37]} {RNA1310_19147.1} {RNA815_8553.1} Mlig455_050659 {REF} {Length: 1670} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=69.9]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=148, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=144, Expect=1e-37]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=141, Expect=1e-36]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=141, Expect=9e-37]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=134, Expect=4e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=7e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=141, Expect=6e-37]} {RNA1310_19147.1} {RNA815_8553.1} |
72. | MligTC455_43676 | 56 | 1.16 | Mlig455_058053, Mlig455_058096 | Neo: - Age: - |
2.699 | 0.972 | - | 0.775 | 0.952 | - | - | Mlig455_058053 {REF} {Length: 391} {NoTransDecoderORF} {RNA1509_25254} {RNA1310_102705} {RNA815_52459} Mlig455_058096 {REF} {Length: 1983} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=51.3]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [Score=90.1, Expect=1e-19]} {RNA1509_1472} {RNA1310_25467} {RNA815_39314} |
|
73. | MligTC455_22264 | 847 | 17.64 | Mlig455_066237 | Neo: - Age: Down-Down-Up Region-specific R2: 2.949 Region-enriched R2: 2.297/0.00062 |
2.693 | - | 0.840 | 0.888 | - | 0.965 | - | Mlig455_066237 {REF} {Length: 741} {Smed: dd_Smed_v6_4417_0_1, dd_Smed_v6_4417_0_1, [Score=40.8, Expect=1e-05]} {RNA1509_19386, RNA1509_31554} {RNA1310_48041.1, RNA1509_19386, RNA1509_31554} {RNA1509_19386, RNA1509_31554, RNA815_28750} | |
74. | MligTC455_12037 | 183 | 3.81 | Mlig455_016647, Mlig455_016711 | Neo: - Age: Down-Up-Up |
DYNLL1 | 2.678 | - | - | 0.835 | 0.987 | 0.856 | - | Mlig455_016647 {REF} {Length: 879} {Pfam: Dynein light chain type 1 [PF01221.20, score=69.4]} {Human: ENSG00000088986, DYNLL1, dynein light chain LC8-type 1, [Score=62.8, Expect=7e-14]; ENSG00000264364, DYNLL2, dynein light chain LC8-type 2, [Score=60.1, Expect=7e-13]} {Mouse: ENSMUSG00000009013, Dynll1, dynein light chain LC8-type 1, [Score=62.8, Expect=4e-14]; ENSMUSG00000020483, Dynll2, dynein light chain LC8-type 2, [Score=60.1, Expect=5e-13]} {Dmel: FBgn0011760, ctp, cut up, [Score=60.5, Expect=2e-13]} {Celegans: WBGene00001005, dlc-1, Dynein light chain 1, cytoplasmic, [Score=59.3, Expect=6e-13]} {Smed: dd_Smed_v6_10084_0_2, dd_Smed_v6_10084_0_2, [Score=65.9, Expect=1e-15]} {RNA1509_36890} {RNA1310_30005} {RNA815_41098} Mlig455_016711 {REF} {Length: 890} {Pfam: Dynein light chain type 1 [PF01221.20, score=69.4]} {Human: ENSG00000088986, DYNLL1, dynein light chain LC8-type 1, [Score=62.8, Expect=5e-14]; ENSG00000264364, DYNLL2, dynein light chain LC8-type 2, [Score=60.1, Expect=7e-13]} {Mouse: ENSMUSG00000009013, Dynll1, dynein light chain LC8-type 1, [Score=62.8, Expect=4e-14]; ENSMUSG00000020483, Dynll2, dynein light chain LC8-type 2, [Score=60.1, Expect=5e-13]} {Dmel: FBgn0011760, ctp, cut up, [Score=60.8, Expect=2e-13]} {Celegans: WBGene00001005, dlc-1, Dynein light chain 1, cytoplasmic, [Score=59.3, Expect=5e-13]} {Smed: dd_Smed_v6_10084_0_5, dd_Smed_v6_10084_0_5, [Score=65.9, Expect=1e-15]} {RNA1509_36890} {RNA1310_30005} {RNA815_41098} |
75. | MligTC455_14216 | 241 | 5.03 | Mlig455_044260 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.597/0.00013 |
DBH | 2.674 | - | - | 0.790 | 0.908 | 0.976 | - | Mlig455_044260 {REF} {Length: 840} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=26.2]} {Human: ENSG00000123454, DBH, dopamine beta-hydroxylase, [Score=70.9, Expect=4e-15]} {Mouse: ENSMUSG00000000889, Dbh, dopamine beta hydroxylase, [Score=72.0, Expect=1e-15]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=64.7, Expect=3e-13]} {Celegans: WBGene00006541, tbh-1, Tyramine beta-hydroxylase, [Score=52.4, Expect=5e-09]} {Smed: dd_Smed_v6_42610_0_1, dd_Smed_v6_42610_0_1, [Score=65.1, Expect=1e-13]} {RNA1509_17014} {RNA1310_13801} {RNA815_8852} |
76. | MligTC455_33848 | 177 | 3.7 | Mlig455_000010, Mlig455_000046 | Neo: - Age: logFC(26M/2M)=-0.353 |
GRIA2 | 2.667 | - | - | - | 0.776 | 0.972 | 0.919 | Mlig455_000010 {REF} {Length: 3793} {Pfam: Ligand-gated ion channel [PF00060.28, score=148.7]; Receptor family ligand binding region [PF01094.30, score=103.6]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=41.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=22.2]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=462, Expect=2e-146]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=456, Expect=1e-143]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=453, Expect=9e-143]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=449, Expect=2e-141]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=459, Expect=1e-145]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=457, Expect=2e-144]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=457, Expect=2e-144]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=449, Expect=1e-141]} {Dmel: FBgn0004619, GluRIA, Glutamate receptor IA, [Score=399, Expect=1e-121]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [Score=328, Expect=3e-96]} {Smed: dd_Smed_v6_19602_0_1, dd_Smed_v6_19602_0_1, [Score=522, Expect=4e-169]} {RNA1509_28586} {RNA1310_3529} {RNA815_7464} Mlig455_000046 {REF} {Length: 3946} {Pfam: Ligand-gated ion channel [PF00060.28, score=148.4]; Receptor family ligand binding region [PF01094.30, score=125.5]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=125.0]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=83.5]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [RH, Score=561, Expect=0.0]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [RH, Score=550, Expect=2e-179]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [RH, Score=545, Expect=2e-177]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [RH, Score=557, Expect=0.0]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [RH, Score=545, Expect=9e-178]} {Dmel: FBgn0004619, GluRIA, Glutamate receptor IA, [RH, Score=521, Expect=2e-167]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [RH, Score=390, Expect=4e-119]} {Smed: dd_Smed_v6_19602_0_1, dd_Smed_v6_19602_0_1, [RH, Score=681, Expect=0.0]} {RNA1509_28586} {RNA1310_3529} {RNA815_7464} |
77. | MligTC455_34692 | 37 | 0.77 | Mlig455_017379 | Neo: - Age: - |
2.661 | 0.966 | - | 0.709 | 0.986 | - | - | Mlig455_017379 {REF} {Length: 579} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_10294} {RNA1310_2672} {RNA815_25099} | |
78. | MligTC455_42493 | 77 | 1.6 | Mlig455_033955 | Neo: - Age: - |
2.657 | - | 0.956 | - | 0.782 | 0.919 | - | Mlig455_033955 {REF} {Length: 878} {Smed: dd_Smed_v6_14508_0_1, dd_Smed_v6_14508_0_1, [RH, Score=75.9, Expect=3e-16]} {RNA1310_57572} | |
79. | MligTC455_46581 | 31 | 0.64 | Mlig455_042524 | Neo: - Age: - |
2.654 | 0.972 | - | 0.718 | 0.964 | - | - | Mlig455_042524 {REF} {Length: 975} {RNA1509_46101} {RNA1310_32444} {RNA815_42659} | |
80. | MligTC455_14685 | 3975 | 82.82 | Mlig455_051429 | Neo: - Age: - Region-specific R2: 2.895 Region-enriched R2: 2.262/0.00004 |
PAM | 2.652 | - | 0.981 | 0.822 | - | 0.849 | - | Mlig455_051429 {REF} {Length: 1911} {Pfam: NHL repeat [PF01436.23, score=59.1]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [Score=119, Expect=2e-28]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=115, Expect=2e-27]} {Dmel: FBgn0262728, Pal2, Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase 2, [Score=115, Expect=2e-28]} {Celegans: WBGene00017671, pgal-1, Probable peptidyl-alpha-hydroxyglycine alpha-amidating lyase pgal-1, [Score=125, Expect=2e-32]} {Smed: dd_Smed_v6_3093_0_1, dd_Smed_v6_3093_0_1, [Score=138, Expect=4e-37]} {RNA1509_910} {RNA1310_18216.1} {RNA815_736.1} |
81. | MligTC455_47949 | 48 | 1 | Mlig455_026482, Mlig455_026492 | Neo: - Age: - |
CHRNA3 | 2.651 | 0.963 | - | - | 0.788 | 0.900 | - | Mlig455_026482 {REF} {Length: 2240} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=248.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=225.1]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=398, Expect=8e-133]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=382, Expect=5e-127]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=382, Expect=2e-126]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=398, Expect=4e-133]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=397, Expect=5e-133]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=384, Expect=1e-127]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=473, Expect=1e-161]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=445, Expect=7e-152]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=416, Expect=2e-140]} {RNA1310_45284} {RNA815_36657} Mlig455_026492 {REF} {Length: 1090} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=248.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=225.1]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=398, Expect=8e-133]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=382, Expect=5e-127]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=382, Expect=2e-126]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=398, Expect=4e-133]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=397, Expect=5e-133]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=384, Expect=1e-127]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=473, Expect=1e-161]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=445, Expect=7e-152]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=416, Expect=2e-140]} {RNA1310_45284} {RNA815_36657} |
82. | MligTC455_46285 | 568 | 11.84 | Mlig455_063390 | Neo: - Age: logFC(26M/2M)=0.488 Region-enriched R2: 4.933/0.00026 |
2.65 | - | 0.849 | 0.850 | 0.951 | - | - | Mlig455_063390 {REF} {Length: 871} {RNA1509_48573} {RNA1310_59611, RNA1509_48573} {RNA1509_48573, RNA815_35731} | |
83. | MligTC455_51200 | 66 | 1.37 | Mlig455_057090 | Neo: - Age: - |
2.648 | - | 0.906 | 0.767 | 0.975 | - | - | Mlig455_057090 {REF} {Length: 988} {RNA1310_63663} {RNA815_36272} | |
84. | MligTC455_43561 | 47 | 0.98 | Mlig455_019076, Mlig455_064291 | Neo: - Age: - |
ASIC3 | 2.641 | 0.984 | - | 0.741 | 0.916 | - | - | Mlig455_019076 {REF} {Length: 2496} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=274.8]} {Human: ENSG00000213199, ASIC3, acid sensing ion channel subunit 3, [RH, Score=122, Expect=5e-29]} {Mouse: ENSMUSG00000020704, Asic2, acid-sensing (proton-gated) ion channel 2, [Score=114, Expect=1e-26]} {Dmel: FBgn0030795, ppk28, pickpocket 28, [Score=58.5, Expect=9e-09]} {Celegans: WBGene00012137, asic-2, Degenerin-like protein asic-2, [Score=133, Expect=5e-33]} {Smed: dd_Smed_v6_17021_0_1, dd_Smed_v6_17021_0_1, [Score=127, Expect=4e-31]} {RNA1509_37765} {RNA1310_15854} {RNA815_39159} Mlig455_064291 {REF} {Length: 2206} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=52.6]} {Celegans: WBGene00012137, asic-2, Degenerin-like protein asic-2, [Score=46.6, Expect=1e-06]} {Smed: dd_Smed_v6_26469_0_1, dd_Smed_v6_26469_0_1, [Score=47.8, Expect=1e-07]} {RNA1509_37765} {RNA1310_15854} {RNA815_28789} |
85. | MligTC455_14898 | 41 | 0.86 | Mlig455_011988 | Neo: - Age: - |
2.64 | - | - | 0.717 | 0.986 | 0.937 | - | Mlig455_011988 {REF} {Length: 858} {Pfam: Lectin C-type domain [PF00059.23, score=28.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1} | |
86. | MligTC455_48604 | 173 | 3.6 | Mlig455_031074 | Neo: - |
2.639 | - | 0.735 | 0.969 | - | 0.935 | - | Mlig455_031074 {REF} {Length: 652} {RNA1310_66509} | |
87. | MligTC455_21974 | 1557 | 32.43 | Mlig455_021416 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.546 Region-specific R2: 3.190 Region-enriched R2: 2.971/0.00000 |
BMPER | 2.638 | - | 0.913 | - | 0.771 | 0.954 | - | Mlig455_021416 {REF} {Length: 22453} {Pfam: Domain of unknown function (DUF1943) [PF09172.13, score=157.5]; von Willebrand factor type D domain [PF00094.27, score=57.2]; Domain of Unknown Function (DUF1081) [PF06448.13, score=32.7]; C8 domain [PF08742.13, score=24.8]; Neurensin [PF14927.8, score=24.5]} {Human: ENSG00000164619, BMPER, BMP binding endothelial regulator, [Score=79.0, Expect=2e-13]; ENSG00000135253, KCP, kielin/chordin-like protein, [Score=79.0, Expect=3e-13]; ENSG00000275395, FCGBP, Fc fragment of IgG binding protein, [Score=76.6, Expect=2e-12]} {Mouse: ENSMUSG00000031963, Bmper, BMP-binding endothelial regulator, [Score=77.0, Expect=6e-13]} {Dmel: FBgn0032136, Apoltp, Apolipoprotein lipid transfer particle, [Score=226, Expect=7e-58]} {Smed: dd_Smed_v6_194_0_1, dd_Smed_v6_194_0_1, [Score=241, Expect=9e-63]} {RNA1509_31} {RNA1310_7.1} {RNA815_4} |
88. | MligTC455_47311 | 16 | 0.33 | Mlig455_045815 | Neo: - Age: - Region-enriched R4: 2.374/0.01691 |
KREMEN2 | 2.638 | 0.967 | - | 0.837 | 0.834 | - | - | Mlig455_045815 {REF} {Length: 1747} {Pfam: WSC domain [PF01822.21, score=57.3]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=58.5, Expect=2e-09]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=58.2, Expect=3e-09]; ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=55.5, Expect=2e-08]} {RNA1509_46373} {RNA1310_44003} {RNA815_48857} |
89. | MligTC455_52726 | 213 | 4.44 | Mlig455_032119 | Neo: - Age: - Region-enriched R2: 4.573/0.00005 |
2.636 | 0.946 | - | - | 0.970 | 0.720 | - | Mlig455_032119 {REF} {Length: 2626} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=61.9]; Capsular polysaccharide synthesis protein [PF05704.14, score=21.0]} {Smed: dd_Smed_v6_6819_0_1, dd_Smed_v6_6819_0_1, [Score=137, Expect=2e-37]} {RNA1509_41314} {RNA1310_26265} {RNA815_9794.1} | |
90. | MligTC455_40905 | 53 | 1.1 | Mlig455_002794, Mlig455_002809 | Neo: - Age: - |
CHL1 | 2.634 | 0.960 | - | 0.752 | - | 0.922 | - | Mlig455_002794 {REF} {Length: 4845} {Pfam: Immunoglobulin domain [PF13927.8, score=205.6]; Immunoglobulin I-set domain [PF07679.18, score=151.2]; Immunoglobulin domain [PF00047.27, score=122.8]; Immunoglobulin domain [PF13895.8, score=109.6]; Fibronectin type III domain [PF00041.23, score=98.8]; Immunoglobulin V-set domain [PF07686.19, score=65.4]; Immunoglobulin domain [PF18452.3, score=21.7]} {Human: ENSG00000134121, CHL1, cell adhesion molecule L1 like, [RH, Score=340, Expect=1e-96]} {Mouse: ENSMUSG00000031391, L1cam, L1 cell adhesion molecule, [RH, Score=339, Expect=2e-96]; ENSMUSG00000030077, Chl1, cell adhesion molecule L1-like, [RH, Score=335, Expect=4e-95]} {Dmel: FBgn0264975, Nrg, Neuroglian, [Score=358, Expect=2e-103]} {Celegans: WBGene00002243, lad-2, Immunoglobulin domain-containing protein Y54G2A.25; L1 CAM ADhesion molecule homolog; LAD-2 long isoform, [Score=287, Expect=1e-79]} {Smed: dd_Smed_v6_1916_0_1, dd_Smed_v6_1916_0_1, [Score=486, Expect=3e-148]} {RNA1310_42673} Mlig455_002809 {REF} {Length: 4785} {Pfam: Immunoglobulin domain [PF13927.8, score=155.8]; Immunoglobulin I-set domain [PF07679.18, score=111.7]; Fibronectin type III domain [PF00041.23, score=99.0]; Immunoglobulin domain [PF00047.27, score=90.9]; Immunoglobulin domain [PF13895.8, score=77.2]; Immunoglobulin V-set domain [PF07686.19, score=38.0]} {Human: ENSG00000134121, CHL1, cell adhesion molecule L1 like, [Score=292, Expect=8e-81]; ENSG00000163531, NFASC, neurofascin, [Score=290, Expect=4e-80]} {Mouse: ENSMUSG00000031391, L1cam, L1 cell adhesion molecule, [Score=294, Expect=2e-81]; ENSMUSG00000026442, Nfasc, neurofascin, [Score=290, Expect=2e-80]; ENSMUSG00000030077, Chl1, cell adhesion molecule L1-like, [Score=285, Expect=2e-78]; ENSMUSG00000020598, Nrcam, neuronal cell adhesion molecule, [Score=282, Expect=7e-78]} {Dmel: FBgn0264975, Nrg, Neuroglian, [Score=315, Expect=1e-88]} {Celegans: WBGene00002243, lad-2, Immunoglobulin domain-containing protein Y54G2A.25; L1 CAM ADhesion molecule homolog; LAD-2 long isoform, [Score=251, Expect=9e-68]} {Smed: dd_Smed_v6_1916_0_1, dd_Smed_v6_1916_0_1, [Score=441, Expect=4e-132]} {RNA1310_42673} |
91. | MligTC455_53609 | 596 | 12.41 | Mlig455_044296 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.314 Region-enriched R2: 5.752/0.03997 |
2.634 | - | - | 0.972 | 0.742 | 0.920 | - | Mlig455_044296 {REF} {Length: 1128} {RNA1509_40777} {RNA1310_31452.1} {RNA815_12344.1} | |
92. | MligTC455_44713 | 661 | 13.77 | Mlig455_048154 | Neo: - Age: logFC(26M/2M)=0.569 Region-specific R2: 3.883 Region-enriched R2: 3.422/0.00000 |
2.633 | - | 0.974 | - | 0.786 | 0.873 | - | Mlig455_048154 {REF} {Length: 1173} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
93. | MligTC455_01421 | 9 | 0.2 | Mlig455_020111 | Neo: - Age: - |
2.628 | 0.972 | - | 0.837 | 0.819 | - | - | Mlig455_020111 {REF} {Length: 880} {Pfam: WSC domain [PF01822.21, score=53.2]; PAN domain [PF00024.28, score=20.6]} {RNA1509_53783} {RNA1310_34968.1} {RNA815_9084.1} | |
94. | MligTC455_08342 | 11 | 0.24 | Mlig455_069886 | Neo: - Age: - |
2.628 | 0.972 | - | 0.837 | 0.819 | - | - | Mlig455_069886 {REF} {Length: 980} {Pfam: WSC domain [PF01822.21, score=48.3]; PAN domain [PF00024.28, score=22.0]} {RNA1509_53783} {RNA1310_34968.1} {RNA815_24434} | |
95. | MligTC455_12113 | 72 | 1.5 | Mlig455_001687, Mlig455_071131 | Neo: - Age: - |
2.624 | - | - | 0.815 | 0.979 | 0.830 | - | Mlig455_001687 {REF} {Length: 809} {RNA1310_67367} {RNA815_37220} Mlig455_071131 {REF} {Length: 452} {RNA1509_45496} {RNA1310_67367} {RNA815_37220} |
|
96. | MligTC455_36194 | 30 | 0.61 | Mlig455_064360, Mlig455_064382 | Neo: - Age: - |
B3GNT4 | 2.621 | - | 0.977 | 0.723 | - | 0.921 | - | Mlig455_064360 {REF} {Length: 3119} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.0, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=3e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.2, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=91.7, Expect=1e-19]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} Mlig455_064382 {REF} {Length: 3084} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.4, Expect=2e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=92.0, Expect=9e-20]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} |
97. | MligTC455_37989 | 83 | 1.72 | Mlig455_018192 | Neo: - Age: - |
2.62 | - | - | 0.767 | 0.992 | 0.861 | - | Mlig455_018192 {REF} {Length: 1275} {Pfam: EF-hand domain pair [PF13499.8, score=36.8]; EF-hand domain [PF13405.8, score=31.2]; EF hand [PF00036.34, score=29.3]; EF-hand domain pair [PF13833.8, score=20.5]; EF hand [PF13202.8, score=19.4]} {Smed: dd_Smed_v6_1010_0_1, dd_Smed_v6_1010_0_1, [Score=105, Expect=6e-27]} {RNA1310_31713.1} {RNA815_36423} | |
98. | MligTC455_17566 | 28 | 0.58 | Mlig455_054331 | Neo: - Age: - |
2.617 | - | 0.969 | 0.789 | 0.859 | - | - | Mlig455_054331 {REF} {Length: 549} {RNA1310_73705} {RNA815_38857} | |
99. | MligTC455_45913 | 4034 | 84.05 | Mlig455_017927 | Neo: - Age: Down-Up-Up Region-specific R2: 3.031 Region-enriched R2: 2.341/0.00000 Regeneration-downregulated BL: -1.976 Regeneration-depleted BL: -1.976 |
2.617 | - | 0.955 | - | 0.733 | 0.929 | - | Mlig455_017927 {REF} {Length: 1006} {RNA1509_22540, RNA1509_32903, RNA1509_3805} {RNA1310_38334, RNA1509_22540, RNA1509_32903, RNA1509_3805} {RNA1509_22540, RNA1509_32903, RNA1509_3805, RNA815_18393} | |
100. | MligTC455_21975 | 1445 | 30.1 | Mlig455_067235 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=0.598 Region-specific R2: 3.235 Region-enriched R2: 3.090/0.00000 |
BMPER | 2.615 | - | 0.896 | - | 0.763 | 0.956 | - | Mlig455_067235 {REF} {Length: 21751} {Pfam: von Willebrand factor type D domain [PF00094.27, score=57.1]; C8 domain [PF08742.13, score=24.9]; Neurensin [PF14927.8, score=24.8]} {Human: ENSG00000164619, BMPER, BMP binding endothelial regulator, [Score=80.9, Expect=4e-14]; ENSG00000135253, KCP, kielin/chordin-like protein, [Score=78.6, Expect=4e-13]; ENSG00000275395, FCGBP, Fc fragment of IgG binding protein, [Score=78.6, Expect=5e-13]} {Mouse: ENSMUSG00000031963, Bmper, BMP-binding endothelial regulator, [Score=78.6, Expect=2e-13]} {Dmel: FBgn0032136, Apoltp, Apolipoprotein lipid transfer particle, [Score=226, Expect=6e-58]} {Smed: dd_Smed_v6_194_0_1, dd_Smed_v6_194_0_1, [Score=244, Expect=8e-64]} {RNA1509_13513, RNA1509_26457, RNA1509_30456, RNA1509_31, RNA1509_5282} {RNA1310_7.1, RNA1509_13513, RNA1509_26457, RNA1509_30456, RNA1509_5282} {RNA1509_13513, RNA1509_26457, RNA1509_30456, RNA1509_5282, RNA815_4} |